top of page

Scientists Create the First Model of a Pre-Embryo from Skin Cells

  • Writer: Ishvita Sharma
    Ishvita Sharma
  • May 4, 2021
  • 2 min read

Updated: May 24, 2021


Images of iBlastoids with different cellular staining. Credit: Monash University

An international team of scientists from Monash University in Melbourne, Australia has created a model of a human embryo by using skin cells. The team accomplished the feat of reprogramming the fibroblasts (skin cells) into a 3-D cell formation that has the structure and functionalities alike to human blastocysts (the stage where the human embryo reaches days 5-9 after fertilization). These models are called iBlastoids.


The iBlastoids were generated using a procedure called “nuclear reprogramming”, which changed the cellular identity (expression, activity, or certain genes) of the fibroblasts, and formed into blastocyst-alike structures. They replicate genetics and anatomy with the inner mass containing epiblast-like cells, and the exterior made up of trophectoderm-like cells.


In functioning human embryos, the epiblast becomes the embryo proper (which develops to be the mature embryo) and the trophectoderm becomes the placenta. Though, it does not have all similar structures; normal blastocysts are surrounded with zona pellucida, the membrane that comes from the egg and links with sperm during fertilization. iBlastoids do not have zona pellucida; as they are not equal human blastocysts, but are good models for biology.


The further study of iBlastoids can lead to finding causes for miscarriages in early stages of pregnancy. It is not intended to be used for human reproduction. Previously, such studies could only obtain blastocysts through IVF methods among other ethical concerns.


As said by Professor Polo, “iBlastoids will allow scientists to study the very early steps in human development and some of the cases of infertility, congenital diseases and the impact of toxins and viruses on early embryos- without the use of human blastocysts and, importantly, at an unprecedented scale, accelerating our understanding and the development of new therapies.


Comments


Post: Blog2 Post
bottom of page